Course Description

Course Fee: $340
CME Credits: 5.0
(Scroll for CME details.)

In this four-module course for clinicians of all specialties, Dr. Greenblatt makes the case for a functional and integrative medical approach to anxiety that moves away from traditional symptom classification and polypharmaceutical approaches to anxiety disorders. Protocols for patient testing are offered alongside specific nutritional interventions to address anxiogenic physiology, as well as other integrative treatments—exercise, yoga, and herbal supplements—that will enable you to maximize therapeutic interventions for your patients.

Learning Objectives:

Upon completion of this course, registrants will be able to:

  • Identify the key genetic, nutritional, metabolic, and environmental causes of anxiety
  • Evaluate the role of inflammation, gut microbiota, amino acids (and other nutritional deficiencies) in the presentation of symptoms of anxiety
  • Describe the benefits of lifestyle therapies
Enroll Now

Modules

1. Anxiety Redefined

We begin by examining current DSM classifications and pharmacological interventions in the treatment of anxiety. Dr. Greenblatt then shifts to a discussion of “THE ZEEBRA” method, which is his acronym for a comprehensive evaluation of all the factors that lead to affective disorders. The final section is devoted to key nutrients associated with the symptoms of anxiety—magnesium, vitamin B3, and vitamin B12—and lab testing protocols and supplementation for its treatment.

2. Exploring Etiology in Anxiety and OCD

Module 2 commences with one of the fastest-growing areas of research in functional psychiatry: the gut-mind connection. For our purposes, we examine gut dysbiosis and Clostridia overgrowth, and the current probiotic therapies in the treatment of anxiety. Next, we look at misdiagnoses of OCD disorder, and how amino acid depletion fits with an orthomolecular model of anxiety.

3. Enhancing Neurotransmission, Eliminating Inflammation

Module 3 explores the contributing factors of folate deficiency, opioid peptides (derived from wheat and dairy), systemic inflammation, and vitamin D deficiency in the presentation of anxiety symptoms. We will also take a close look at inositol as a mechanism for serotonergic signaling.

4. Expanding the Therapeutic Arsenal

The final module provides functional and integrative medicine treatments for anxiety, including N-acetyl-cysteine (NAC), nutritional lithium, I-theanine, GABA, ashwagandha, cannabidiol, along with “vitamin E” (exercise) and “vitamin Y” (yoga).

CME Details

DURATION OF ACTIVITY
April 4, 2022 through April 3, 2024

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME and Comprehensive Psychiatric Resources, Inc.  MedicusCME is accredited by the ACCME to provide continuing medical education for physicians.

DESIGNATION STATEMENT
MedicusCME designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OVERVIEW
In this four-module course for clinicians of all specialties, Dr. Greenblatt makes the case for a functional and integrative medical approach to anxiety that moves away from traditional symptom classification and polypharmaceutical approaches to anxiety disorders. Protocols for patient testing are offered alongside specific nutritional interventions to address anxiogenic physiology, as well as other integrative treatments—exercise, yoga, and herbal supplements—that will enable you to maximize therapeutic interventions for your patients.

LEARNING OBJECTIVES

  • Identify the key genetic, nutritional, metabolic, and environmental causes of anxiety
  • Evaluate the role of inflammation, gut microbiota, amino acids (and other nutritional deficiencies) in the presentation of symptoms of anxiety
  • Describe the benefits of lifestyle therapies

HOW TO CLAIM CREDIT
In order to receive AMA PRA Category 1 credit™, participants must do the following:

  • Read the learning objectives and faculty disclosures

  • Participate in the activity, review course content and learning strategies, resources and support materials provided

  • Complete the post-test and activity evaluation

  • Achieve a score of 80% or higher on the post-test

PLANNER
Mariela Podolski, MD
Podolski Psychiatry
Adult/Child and Adolescent Psychiatry
West Hartford, Connecticut

Walden Behavioral Care
Director of Child and Adolescent Psychiatry

Eating Disorder Consultant
Department of Corrections, Connecticut

Eating Disorder Consultant
DHMAS/Connecticut Valley Hospital, Connecticut

FACULTY
James Greenblatt, MD
Chief Medical Officer and Vice President of Medical Services
Walden Behavioral Care, Waltham, Massachusetts

Assistant Clinical Professor of Psychiatry
Tufts University School of Medicine
Boston, Massachusetts

DISCLOSURE OF FINANCIAL RELATIONSHIPS
MedicusCME requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to MedicusCME policy.

The faculty reported the following relevant financial relationships with Accreditation Council for Continuing Medical Education (ACCME)-defined ineligible entities related to the educational content of this CE activity.

James Greenblatt, MD has disclosed financial relationships with Fullscripts for an affiliate relationship and with Atrium Health/Pure Encapsulations and Jaymac Pharmaceuticals for participating on their Speakers Boards.

Any relevant financial relationships listed for planners or content contributors have been mitigated according to MedicusCME policies. MedicusCME planners and managers have no relevant financial relationships with ineligible companies to disclose.

ACKNOWLEDGEMENTS
This activity is not supported by funds from an ACCME-defined ineligible company.

HIPPA COMPLIANCE ATTESTATION
In accordance with the Health Insurance Portability and Accountability Act (HIPAA), this educational activity, especially when utilizing patient cases for learning demonstration, will not include individually identifiable health information.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Stay in the know.

Sign-up now for updates, news and exclusive offers! Let’s redefine mental wellness together.

By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.